Related Experiment Video
Updated: Jun 10, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
The PHD3 domain of MLL acts as a CYP33-regulated switch between MLL-mediated activation and repression
Sangho Park1, Ute Osmers, Gayathree Raman
1Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, Virginia 22908, USA.
Abstract:
The mixed lineage leukemia (MLL) gene plays a critical role in epigenetic regulation of gene expression and is a frequent target of chromosomal translocations leading to leukemia. MLL plant homeodomain 3 (PHD3) is lost in all MLL translocation products, and reinsertion of PHD3 into MLL fusion proteins abrogates their transforming activity. PHD3 has been shown to interact with the RNA-recognition motif (RRM) domain of human nuclear Cyclophilin33 (CYP33). Here, we show that CYP33 mediates downregulation of the expression of MLL target genes HOXC8, HOXA9, CDKN1B, and C-MYC, in a proline isomerase-dependent manner. This downregulation correlates with the reduction of trimethylated lysine 4 of histone H3 (H3K4me3) and histone H3 acetylation. We have structurally characterized both the PHD3 and CYP33 RRM domains and analyzed their binding to one another. The PHD3 domain binds H3K4me3 (preferentially) and the CYP33 RRM domain at distinct sites. Our binding data show that binding of H3K4me3 to PHD3 and binding of the CYP33 RRM domain to PHD3 are mutually inhibitory, implying that PHD3 is a molecular switch for the transition between activation and repression of target genes. To explore the possible mechanism of CYP33/PHD3-mediated repression, we have analyzed the CYP33 proline isomerase activity on various H3 and H4 peptides and shown selectivity for two sites in H3. Our results provide a possible mechanism for the MLL PHD3 domain to act as a switch between activation and repression.
Insights
The mixed lineage leukemia (MLL) gene
Area of Science:
- Epigenetics
- Molecular Biology
- Cancer Research
Background:
- The mixed lineage leukemia (MLL) gene is crucial for epigenetic regulation and frequently involved in leukemia-causing translocations.
- Loss of the MLL plant homeodomain 3 (PHD3) in MLL fusion proteins is linked to leukemia, and its reinsertion reduces transforming activity.
Purpose of the Study:
- To investigate the interaction between MLL PHD3 and human nuclear Cyclophilin33 (CYP33) RRM domain.
- To elucidate the mechanism by which CYP33 and PHD3 regulate MLL target gene expression and epigenetic marks.
Main Methods:
- Structural characterization of PHD3 and CYP33 RRM domains.
- Analysis of binding interactions between PHD3, CYP33 RRM, and histone peptides.
- Assay of CYP33 proline isomerase activity on histone peptides.
Main Results:
- CYP33 binding to PHD3 and H3K4me3 binding to PHD3 are mutually inhibitory, indicating PHD3 acts as a molecular switch.
- CYP33 binding to PHD3 mediates downregulation of MLL target genes (HOXC8, HOXA9, CDKN1B, C-MYC).
- This downregulation correlates with reduced H3K4me3 and histone acetylation levels.
Conclusions:
- The MLL PHD3 domain functions as a molecular switch controlling gene activation and repression.
- CYP33's proline isomerase activity and its interaction with PHD3 provide a mechanism for MLL-mediated gene repression.
Related Concept Videos
Master Transcription Regulators
Abnormal Proliferation
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Negative Regulator Molecules

